[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337589-105":59,"doc-detail-337589-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","crispr-based-multiplex-detection-of-human-papillomaviruses-for-one-pot-point-of-care-diagnostics","CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics","","The World Health Organization’s initiative to eliminate high-risk HPV-related cancers prioritizes DNA testing over visual inspection for primary screening and aims to eradicate HPV by 2100. Because different hrHPV types drive different cancers, an easy multiplex point-of-care platform is urgently needed. This study develops a CRISPR-Cas multiplex assay (CRISPRD) for one-reaction detection of hrHPVs, reporting detection of HPV16 and HPV18 with 10-copy sensitivity and 100% specificity, plus an internal control, enabling rapid large-scale screening.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/crispr-based-multiplex-detection-of-human-papillomaviruses-for-one-pot-point-of-care-diagnostics/337589/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/crispr-based-multiplex-detection-of-human-papillomaviruses-for-one-pot-point-of-care-diagnostics/337589.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is DNA testing recommended over visual inspection for primary HPV screening?","Question",{"text":112,"@type":113},"The WHO global initiative favors DNA testing because it better supports effective primary screening and eradication goals, whereas visual inspection is less reliable for identifying high-risk HPV.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the CRISPRD one-pot multiplex diagnostic assay designed to detect?",{"text":117,"@type":113},"CRISPRD is designed to detect cervical cancer-causing high-risk human papillomaviruses in a single reaction, including HPV16 and HPV18, along with an internal control.",{"name":119,"@type":110,"acceptedAnswer":120},"How effective is the CRISPRD platform in terms of sensitivity and specificity?",{"text":121,"@type":113},"The platform achieves a limit of detection of 10 copies and reports 100% specificity for the tested targets within the described one-pot assay approach.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337589,1790169750,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/synthbio](pubs.acs.org/synthbio)  Research Article   \nCRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics  \nAhmed Ghouneimy, Zahir Ali, Rashid Aman, Wenjun Jiang, Mustapha Aouida, and Magdy Mahfouz *  \n Cite This: ACS Synth. Biol. 2024, 13, 837−850  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: The World Health Organization’s global initiative toward eliminating high-risk Human Papillomavirus (hrHPV) -related cancers recommends DNA testing over visual inspection in all settings for primary cancer screening and HPV eradication by 2100. However, multiple hrHPV types cause different types of cancers, and there is a pressing need for an easy-to-use, multiplex point-of-care diagnostic platform for detecting different hrHPV types. Recently, CRISPR-Cas systems have been repurposed for point-of-care detection. Here, we established a CRISPR-Cas multiplexed diagnostic assay (CRISPRD) to detect cervical cancer-causing hrHPVs in one reaction (one-pot assay). We harnessed the compatibility of thermostable AapCas12b, TccCas13a, and HheCas13a nucleases with isothermal amplification and successfully detected HPV16 and HPV18, along with an internal control in a single-pot assay with a limit of detection of 10 copies and 100% specificity. This platform offers a rapid and practical solution for the multiplex detection of hrHPVs, which may facilitate large-scale hrHPV point-of-care screening. Furthermore, the CRISPRD platform programmability enables it to be adapted for the multiplex detection of any two nucleic acid biomarkers as well as internal control.  \nKEYWORDS: CRISPR-Cas, human papillomavirus, sexually transmitted infections, molecular diagnostics, multiplex detection, point-of-care detection, cervical cancer  \n■ INTRODUCTION  \nGlobally, human papillomavirus (HPV) infections contribute approximately 4.5% of all malignancies, accounting for 8.6% of cancer cases in women (the third most prevalent cause with a high mortality) and 0.8% of cases in men. 1−3 In 2020, nearly 600,000 women were diagnosed with cervical cancer worldwide, leading to 300,000 associated deaths.4 Based on the severity of this preventable cancer, the World Health Organization (WHO) has issued a global 90−70−90 call-toaction, setting clear targets to reduce cervical cancer by 2030 and irradicate HPV by 2100 through increasing HPV vaccination to 90% of the world’s population, implementing twice-lifetime screening in 70% of the female population, and treating 90% of cervical cancer patients.5 In developed countries, government-funded cancer screening and HPV vaccination programs have reduced the incidence and mortality of cervical cancer. However, in less-developed countries, cervical cancer remains a leading cause of cancerrelated deaths.6  \nHPV infection is transmitted through sexual contact, and it is estimated that 80% of the sexually active population will experience at least one infection with HPV in their life span. Persistent infection by high-risk HPV (hrHPV) strain(s) and expression of HPV oncogenes leads to cervical intraepithelial  \nneoplasia (CIN). Cervical disease is classified into three stages: CIN1 represents the transient infection by HPV and has a high probability (90%) of HPV regression and clearance. CIN2 is the next stage characterized by persistent replication but unproductive infection in the basal layer. CIN3 is the highgrade precancerous stage, and if not regressed, epithelial-layer malignancy leads to cervical cancer.7−9 The progressive nature of HPV infection and CIN provides an HPV-related cancerprevention window as long as HPV is detected early and cervical disease is intercepted in the initial stages (CIN1 or CIN2).  \nThe replicative genome of HPV consists of a doublestranded circular DNA of approximately 7900 ba","cbCaith8YpkU3VqA","https://ap.wps.com/l/cbCaith8YpkU3VqA","pdf",4828030,14,"English","# Abstract\n# Introduction\n## Global burden of HPV and cervical cancer\n## HPV transmission and disease progression\n## HPV genome and oncogenic genotypes","[{\"question\":\"Why is DNA testing recommended over visual inspection for primary HPV screening?\",\"answer\":\"The WHO global initiative favors DNA testing because it better supports effective primary screening and eradication goals, whereas visual inspection is less reliable for identifying high-risk HPV.\"},{\"question\":\"What is the CRISPRD one-pot multiplex diagnostic assay designed to detect?\",\"answer\":\"CRISPRD is designed to detect cervical cancer-causing high-risk human papillomaviruses in a single reaction, including HPV16 and HPV18, along with an internal control.\"},{\"question\":\"How effective is the CRISPRD platform in terms of sensitivity and specificity?\",\"answer\":\"The platform achieves a limit of detection of 10 copies and reports 100% specificity for the tested targets within the described one-pot assay approach.\"}]","CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics | PDF",1790019699,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdb87e620210323a66717be28af3a15f.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74fae139412bc215609068b559402eb0.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da43e79e8f402c339bfd74bc0ef9f05f.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/addbb91b5e08a725d24a977035286cf3.webp",980,1292]